Darier and Hailey-Hailey disease: update 2021 (Abstract) (LDN, low dose naltrexone)

Darier and Hailey-Hailey disease: update 2021 (Abstract) (LDN, low dose naltrexone) J Dtsch Dermatol Ges October 2021 https://pubmed.ncbi.nlm.nih.gov/34661345/ The autosomal-dominant genodermatoses Darier disease and Hailey-Hailey disease present special challenges to dermatologists. Despite their similar pathogenesis featuring impaired adhesion of suprabasal keratinocytes as a result of defective ATPases in epidermal calcium channels, the two diseases differ considerably […]

Variable response to low‐dose naltrexone in patients with Darier disease… (Abstract)

Variable response to low‐dose naltrexone in patients with Darier disease: a case series J Eur Acad Dermatol Venereol 03 February 2019 https://onlinelibrary.wiley.com/doi/abs/10.1111/jdv.15457 Background: Darier disease is a rare autosomal‐dominant genodermatosis with a loss of function of a Ca2+‐ATPase pump (SERCA2‐pump). Clinically, the disease is characterized by red–brown keratotic papules mainly in seborrhoeic areas and has only […]

Naltrexone for the Treatment of Darier and Hailey-Hailey Diseases (Abstract)

Naltrexone for the Treatment of Darier and Hailey-Hailey Diseases J Cutan Med Surg 24 July 2019 https://www.researchgate.net/publication/334649366_Naltrexone_for_the_Treatment_of_Darier_and_Hailey-Hailey_Diseases The use of LDn at 4.5mg once daily in patients with HHD shows promise, doesn’t require laboratory monitoring as classic doses of 50-100mg, and has a favourable safey profile with common side effects of vivid dreams and headache. […]